Drug Type Targeted protein degraders |
Synonyms- |
Target- |
Action- |
Mechanism Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | United States | - | |
Neoplasms | Preclinical | United States | - | |
Nervous System Diseases | Preclinical | United States | - | |
Autoimmune Diseases | Discovery | United States | - | |
Neoplasms | Discovery | United States | - | |
Nervous System Diseases | Discovery | United States | - |